LATA — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-05-15

• Following the Initial Public Offering, including the full exercise of the Over-Allotment Option, and the Private Placement, a total of $172,500,000 was initially placed in the Trust Account. We incurred costs of $10,060,403, consisting of $3,450,000 of cash underwriting fee, the Deferred Fee of $6,0…

• For the three months ended March 31, 2026, cash used in operating activities was $184,208. Net income of $1,373,157 was affected by interest earned on investments held in Trust Account of $1,532,755. Changes in operating assets and liabilities used $24,610 of cash for operating activities.

• As of March 31, 2026, we had investments held in the Trust Account of $175,849,447 (including $3,349,447 of interest income) consisting of U.S. Treasury Bills with a maturity of 185 days or less. We may withdraw interest from the Trust Account to pay taxes, if any. We intend to use substantially all…

• Prior to the closing of our Initial Public Offering, our Sponsor agreed to loan us an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering pursuant to the IPO Promissory Note. The loan was non-interest bearing, unsecured and due at the closing of the In…

• We granted the Underwriters a 45-day option from the date of the Initial Public Offering to purchase up to an additional 2,250,000 Option Units to cover over-allotments, if any. On September 22, 2025, the Underwriters fully exercised their Over-Allotment Option.

Text removed vs the prior filing · source: 10-Q · 2025-11-13

• For the period from June 20, 2025 (inception) through September 30, 2025, we had a net income of $18,492, which consists of interest income on marketable securities held in the Trust Account of $151,164, partially offset by operating and formation costs of $132,672.

• Following the Initial Public Offering, including the full exercise of the Over-Allotment Option, and the Private Placement, a total of $172,500,000 was initially placed in the Trust Account. We incurred costs of $10,060,403, consisting of $3,450,000 of cash underwriting fee, the Deferred Fee of up t…

• For the period from June 20, 2025 (inception) through September 30, 2025, cash used in operating activities was $222,116. Net income of $18,492 was affected by formation costs paid by the Sponsor in exchange for the issuance of the Founder Shares of $14,675, payment of general and administrative cos…

• As of September 30, 2025, we had marketable securities held in the Trust Account of approximately $172,651,164 (including approximately $151,164 of interest income)) consisting of U.S. Treasury Bills with a maturity of 185 days or less. We may withdraw interest from the Trust Account to pay taxes, i…

• Prior to the closing of our Initial Public Offering, our Sponsor agreed to loan us an aggregate of up to $300,000 under the IPO Promissory Note. Such loans and advances were non-interest bearing and payable on the earlier of December 31, 2025 or the completion of our Initial Public Offering. The loa…

Text added vs the prior filing · source: 10-Q · 2026-05-15

• There have been no changes to our internal control over financial reporting during the quarterly period ended March 31, 2026 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting..

Text removed vs the prior filing · source: 10-Q · 2025-11-13

• We may seek to extend the Combination Period, which could reduce the amount held in our Trust Account and have adverse effects on our Company.

• If we are unable to consummate our initial Business Combination on or before September 22, 2027, we may seek shareholder approval to extend the Combination Period by amending our Amended and Restated Articles. In such event, our Public Shareholders will be provided the opportunity to have all or a p…

• We anticipate that our securities will be suspended from trading on Nasdaq and delisted if we do not consummate our initial Business Combination by September 18, 2028. Any trading suspension or delisting could have a material adverse effect on the trading of our securities and may adversely affect o…

• Our IPO Registration Statement was declared effective by the SEC on September 18, 2025, and our securities are currently listed on the Global Market tier of Nasdaq. Pursuant to our Amended and Restated Articles, we have until September 22, 2027 to consummate our initial Business Combination.

• Under the Nasdaq Rules, a SPAC’s Nasdaq-listed securities will be immediately suspended from trading if the SPAC does not meet the Nasdaq 36-Month Requirement, and Nasdaq will, at such point, commence delisting procedures. Although a SPAC can request a hearing before the hearing panel of Nasdaq (the…